Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochlorperazine for AMS Prophylaxis
NCT06450899Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Aug 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prochlorperazine in acute mountain sickness (AMS), sponsored by University of Colorado Denver. Started Aug 2024; status: completed.
02
Drugs
prochlorperazine
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT06450899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06450899.